Retraction: MicroRNA-493 Suppresses Tumor Growth, Invasion and Metastasis of Lung cancer by Regulating E2F1 (PLoS ONE (2014) 9: 8 (e102602) DOI: 10.1371/journal.pone.0102602);MicroRNA-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating E2F1

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Gu, Yixue ^a,b   Cheng, Ye ^a   Song, Ying ^a   Zhang, Zhijie ^a   Deng, Min ^a   Wang, Chengkun ^a   Zheng, Guopei ^a   He, Zhimin ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 493; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; E2F1 PROTEIN, HUMAN; LUCIFERASE; MIRN493 MICRORNA, HUMAN; PRIMER DNA;

3' UNTRANSLATED REGION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; E2F1 GENE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS INHIBITION; MIGRATION INHIBITION; MITOSIS INHIBITION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANALYSIS OF VARIANCE; CELL MOTION; DISEASE COURSE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; NON SMALL CELL LUNG CANCER; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; DNA PRIMERS; E2F1 TRANSCRIPTION FACTOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84905643970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0227503     Document Type: Erratum

References (36)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96. (Pubitemid 351521864)
2. Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, et al. (2013) HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature 505: 212-217.
3. Khromova N, Kopnin P, Rybko V, Kopnin BP (2012) Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms. Oncogene 31: 1389-1397.
4. Yu YH, Chen HA, Chen PS, Cheng YJ, Hsu WH, et al. (2013) MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 32: 431-443.
5. Bae S, Ahn JH, Park CW, Son HK, Kim KS, et al. (2009) Gene and microRNA expression signatures of human mesenchymal stromal cells in comparison to fibroblasts. Cell Tissue Res 335: 565-573.
6. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866. (Pubitemid 44629897)
7. Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, et al. (2010) Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer Res 70: 4163-4173.
8. Doench JG, Sharp PA (2004) Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-511. (Pubitemid 38372808)
9. German MA, Pillay M, Jeong DH, Hetawal A, Luo S, et al. (2008) Global identification of microRNA-target RNA pairs by parallel analysis of RNA ends. Nat Biotechnol 26: 941-946.
10. Hu Z, Chen J, Tian T, Zhou X, Gu H, et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118: 2600-2608. (Pubitemid 351949787)
11. Wang XC, Du LQ, Tian LL, Wu HL, Jiang XY, et al. (2011) Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer 72: 92-99.
12. Xiong F, Wu C, Chang J, Yu D, Xu B, et al. (2011) Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res 71: 5175-5181.
13. Kasinski AL, Slack FJ (2012) miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res 72: 5576-5587.
14. Zhang C, Ge S, Hu C, Yang N, Zhang J (2013) MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer. Acta Biochim Biophys Sin (Shanghai) 45: 1055-1061.
15. Chong JL, Wenzel PL, Saenz-Robles MT, Nair V, Ferrey A, et al. (2009) E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 462: 930-934.
16. Hallstrom TC, Mori S, Nevins JR (2008) An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13: 11-22. (Pubitemid 350309738)
17. Lee JS, Leem SH, Lee SY, Kim SC, Park ES, et al. (2010) Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol 28: 2660-2667.
18. Engelmann D, Putzer BM (2012) The dark side of E2F1: in transit beyond apoptosis. Cancer Res 72: 571-575.
19. Alla V, Engelmann D, Niemetz A, Pahnke J, Schmidt A, et al. (2010) E2F1 in melanoma progression and metastasis. J Natl Cancer Inst 102: 127-133.
20. Calvo F, Agudo-Ibanez L, Crespo P (2010) The Ras-ERK pathway: understanding site-specific signaling provides hope of new anti-tumor therapies. Bioessays 32: 412-421.
21. Campbell PM, Groehler AL, Lee KM, Ouellette MM, Khazak V, et al. (2007) K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res 67: 2098-2106. (Pubitemid 46424228)
22. Okamoto K, Ishiguro T, Midorikawa Y, Ohata H, Izumiya M, et al. (2012) miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver. EMBO J 31: 1752-1763.
23. Ueno K, Hirata H, Majid S, Yamamura S, Shahryari V, et al. (2012) Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. Mol Cancer Ther 11: 244-253.
24. Sakai H, Sato A, Aihara Y, Ikarashi Y, Midorikawa Y, et al. (2014) MKK7 mediates miR-493-dependent suppression of liver metastasis of colon cancer cells. Cancer Sci 105: 425-430.
25. Sharma A, Yeow WS, Ertel A, Coleman I, Clegg N, et al. (2010) The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. J Clin Invest 120: 4478-4492.
26. Muller H, Helin K (2000) The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta 1470: M1-12.
27. Singh P, Wong SH, Hong W (1994) Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J 13: 3329-3338. (Pubitemid 24226948)
28. Xu G, Livingston DM, Krek W (1995) Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci U S A 92: 1357-1361.
29. Gorgoulis VG, Zacharatos P, Mariatos G, Kotsinas A, Bouda M, et al. (2002) Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J Pathol 198: 142-156. (Pubitemid 35243872)
30. Rabbani F, Richon VM, Orlow I, Lu ML, Drobnjak M, et al. (1999) Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J Natl Cancer Inst 91: 874-881. (Pubitemid 29252304)
31. Eymin B, Gazzeri S, Brambilla C, Brambilla E (2001) Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Oncogene 20: 1678-1687. (Pubitemid 32368015)
32. Nelson MA, Reynolds SH, Rao UN, Goulet AC, Feng Y, et al. (2006) Increased gene copy number of the transcription factor E2F1 in malignant melanoma. Cancer Biol Ther 5: 407-412.
33. Saito M, Helin K, Valentine MB, Griffith BB, Willman CL, et al. (1995) Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line. Genomics 25: 130-138.
34. Han S, Park K, Bae BN, Kim KH, Kim HJ, et al. (2003) E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide. Breast Cancer Res Treat 82: 11-16. (Pubitemid 37476014)
35. DeGregori J (2002) The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim Biophys Acta 1602: 131-150.
36. Tang H, Deng M, Tang Y, Xie X, Guo J, et al. (2013) miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin Cancer Res 19: 5602-5612.